Vnitr Lek 2018, 64(4):450-456 | DOI: 10.36290/vnl.2018.064

Cyclic Cushing's syndrome: a case study and overview

Jana Kollerová1,*, Ján Malina2, Andrej Šteňo3, Pavol Povinec4, Juraj Payer1
1 V. interná klinika LF UK a UNB, Nemocnica Ružinov, Bratislava, Slovenská republika
2 Klinika onkologickej chirurgie LF UK a Onkologický ústav sv. Alžbety, Bratislava, Slovenská republika
3 Neurochirurgická klinika LF UK a UNB, Nemocnica Akademika L. Dérera, Bratislava, Slovenská republika
4 Pracovisko BIONT, a.s., Bratislava, Slovenská republika

Cushing's syndrome and especially Cushing's disease represent diagnostically and therapeutically complicated medical situations. In some patients, cyclic changes in cortisol production additionally hamper the diagnosis in terms of source identification and management of hormone overproduction. It may not be clear, whether the patient is cured or not even years after the treatment. It is a rare disorder variant, but we assume that it is underdiagnosed and it's incidence is actually higher. The article deals with a complicated course of diagnosis and treatment in a patient with cyclic Cushing's syndrome.

Keywords: Cushing's disease; cyclic Cushing's syndrome; hypercortisolism

Received: March 23, 2017; Accepted: January 22, 2018; Published: April 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kollerová J, Malina J, Šteňo A, Povinec P, Payer J. Cyclic Cushing's syndrome: a case study and overview. Vnitr Lek. 2018;64(4):450-456. doi: 10.36290/vnl.2018.064.
Download citation

References

  1. Boscaro M, Barzon L, Fallo F et al. Cushing's syndrome. Lancet 2001; 357(9258): 783-791. Dostupné z DOI: <http://dx.doi.org/10.1016/S0140-6736(00)04172-6>. Go to original source... Go to PubMed...
  2. Meinardi JR, Wolffenbuttel BHR, Dullaart RP. Cyclic Cushing's syndrome: a clinical challenge. Eur J Endocrinol 2007; 157(3): 245-254. Dostupné z DOI: <http://dx.doi.org/10.1530/EJE-07-0262>. Go to original source... Go to PubMed...
  3. Alexandraki KI, Kaltsas GA, Isidori AM et al. The prevalence and characteristic features of cyclicity and variability in Cushing's disease. Eur J Endocrinol 2009; 160(6): 1011-1018. Dostupné z DOI: <http://dx.doi.org/10.1530/EJE-09-0046>. Go to original source... Go to PubMed...
  4. Kršek M, Čáp J, Hána V et al. Doporučení České endokrinologické společnosti pro léčbu Cushingova syndromu v dospělosti. Vnitř Lék 2013; 59(9): 819-827. Go to PubMed...
  5. Brown RD, Van Loon GR, Orth DN et al. Cushing's disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone. J Clin Endocrinol Metab 1973; 36(3): 445-451. Dostupné z DOI: <http://dx.doi.org/10.1210/jcem-36-3-445>. Go to original source... Go to PubMed...
  6. Bailey RE. Periodic hormonogenesis - a new phenomenon. Periodicity in function of a hormone-producing tumor in man. J Clin Endocrinol Metab 1971; 32(3): 317-327. Dostupné z DOI: <http://dx.doi.org/10.1210/jcem-32-3-317>. Go to original source... Go to PubMed...
  7. Bassoe HH, Emberland R, Stoa KF. Fluctuating steroid excretion in Cushing's syndrome. Acta Endocrinol (Copenh) 1958; 28(2): 163-168. Go to original source... Go to PubMed...
  8. Orth DN. Cushing's syndrome. N Engl J Med 1995; 332(12): 791-803. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJM199503233321207>. Erratum in N Engl J Med 1995; 332(22): 1527. Go to original source... Go to PubMed...
  9. Petersenn S, Newell-Price J, Findling JW et al. High variability in baseline urinary free cortisol values in patients with Cushing's disease. Clin Endocrinol (Oxf) 2014; 80(2): 261-269. Dostupné z DOI: <http://dx.doi.org/10.1111/cen.12259>. Go to original source... Go to PubMed...
  10. Atkinson B, Mullan KR. What is the best approach to suspected cyclical Cushing syndrome? Strategies for managing Cushing's syndrome with variable laboratory data. Clin Endocrinol (Oxf) 2011; 75(1): 27-30. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365-2265.2011.04033.x>. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.